人工智慧（AI）診斷市場（按組件、診斷類型和地區）

Artificial Intelligence Diagnostics Market, By Component, By Diagnostics Type, By Region

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

人工智慧 (AI) 診斷市場在 2025 年的價值估計為 22.078 億美元，預計到 2032 年將達到 84.816 億美元，2025 年至 2032 年的複合年成長率為 21.2%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	22.078億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	21.20%	2032年價值預測	84.816億美元

人工智慧 (AI) 在醫療保健領域擁有巨大潛力，它能夠快速深入地分析大量數據。在體外診斷 (IVD) 等領域，這可能會帶來變革性的影響。正因如此，醫療保健領域對人工智慧技術的需求日益成長。

市場動態：

隨著人工智慧 (AI) 的發展和應用，醫學診斷實踐正在迅速改變。隨著電腦處理能力的不斷提升，基於 AI 的系統如今能夠為各個專業領域提供精準高效的診斷和治療管理方案。由於計算能力、學習演算法、雲端儲存以及電子健康記錄資料集可用性等方面的進步，AI 將在診斷和醫療保健領域發揮重要作用。 AI 將使放射科醫生和病理學家能夠在早期準確診斷病情，從而提供適當有效的治療。

2017 年 12 月的一篇關於人工智慧在放射學研究中的應用的 PubMed 論文指出，下一個突破不是來自創新的放射學設備，而是來自人工智慧的整合。這種整合可能會分階段進行。基於人工智慧的設備從超音波、MRI、CT 和 PET 等影像技術中收集數據。作為第一步，人工智慧已經對各種影像資料和結構進行自動分割，提供了重要的分析價值並幫助放射科醫生縮短時間。在未來十年，基於人工智慧的放射學解決方案可能會用於在放射科醫生進行分析之前執行量化、分割和模式識別等常規任務，從而改善患者照護的服務。

本研究的主要特點

本報告對全球人工智慧 (AI) 診斷市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 2025-2032 的市場規模和複合年成長率。
它還揭示了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
全球人工智慧 (AI) 診斷市場的主要企業會根據以下參數進行分析，例如公司亮點、產品系列、關鍵亮點、財務表現和策略。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球人工智慧 (AI) 診斷市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球人工智慧 (AI) 診斷市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 2,207.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	21.20%	2032 Value Projection:	USD 8,481.6 Mn

Artificial intelligence (AI) has powerful potential within healthcare, promising the ability to analyze vast amounts of data quickly and in detail. In a field such as in vitro diagnostics (IVD), which could have transformative implications. Thus, there is an increasing demand for artificial intelligence technology in healthcare sector.

Market Dynamics:

The practice of medical diagnostics is rapidly changing with the development and adoption of Artificial Intelligence (AI). Constant improvements in computer processing have enabled AI-based systems to provide accurate and efficient diagnosis & treatment management plans across various specializations. AI can play a big role in diagnosis and healthcare, with advancements in computing power, learning algorithms, cloud storage, and availability of datasets from electronic health records. It can enable radiologists and pathologists to accurately diagnosis conditions at an early stage to provide adequate & effective treatment.

In a PubMed article on applications of AI in radiology, in December 2017, it was studied that the next breakthrough would not be through an innovative radiology device but through the integration of AI. This integration is likely to take place in stages. AI-based devices are collecting data from imaging technologies, such as ultrasound, MRI, CT, and PET. In its first stage, AI is already performing automatic segmentation of various imaging data and structures to yield significant analytical value and help save the radiologist's time. Over the next decade, AI-based radiology solutions are likely to be used to perform routine tasks such as quantification, segmentation, and pattern recognition prior to the radiologist's analysis, thereby improving patient care delivery.

Key features of the study:

This report provides in-depth analysis of the global artificial intelligence (AI) diagnosis market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global artificial intelligence (AI) diagnosis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Vuno Inc., CHC Healthcare Group, Aidoc, Imbio, Alivecor Inc., Digital Diagnostics, Retina AI, Canon Medical Systems USA, Healthy Io, Milliman Inc., GE Healthcare, Arterys, Alivecor Inc., Riverain, Lucid Health, Qure.AI, and Cardiologs, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global artificial intelligence (AI) diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) diagnosis market.

Detailed Segmentation:

Global Artificial Intelligence Diagnostics Market, By Component:
- Software
- Hardware
- Services
Global Artificial Intelligence Diagnostics Market, By Diagnosis Type:
- Cardiology
- Oncology
- Pathology
- Radiology
- Neurology
- Others
Global Artificial Intelligence Diagnostics Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Vuno Inc.
- CHC Healthcare Group
- Aidoc
- Imbio
- Alivecor Inc.
- Digital Diagnostics
- Retina AI
- Canon Medical Systems USA
- Healthy IO
- Milliman Inc.
- GE Healthcare
- Arterys
- Alivecor Inc.
- Riverain
- Lucid Health
- Qure.AI
- Cardiologs

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Component
- Market Snapshot, By Service Type
- Market Snapshot, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising incidence of infectious diseases
- Concerns about the use of thermometers
- High demand for Artificial Intelligence (AI) diagnostics devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Artificial Intelligence (AI) Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Artificial Intelligence (AI) Diagnostics Market, By Component, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Artificial Intelligence (AI) Diagnostics Market, By Diagnostics Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pathology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Radiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Artificial Intelligence (AI) Diagnostics Market, By Geography, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostics Type, 2020-2032,(US$ Mn)

8. Competitive Landscape

Vuno Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CHC Healthcare Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aidoc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Imbio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alivecor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Digital Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Retina AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Canon Medical Systems USA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Healthy IO
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Milliman Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Arterys
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alivecor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Riverain
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lucid Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qure.AI
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardiologs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views